Arvinas (ARVN) Net Cash Flow (2017 - 2026)

Arvinas' (ARVN) quarterly Net Cash Flow came in at -$55.6 million in Q1 2026, down 185.13% year-on-year from $65.3 million in Q1 2025, and down 234.3% quarter-over-quarter from $41.4 million in Q4 2025.

Arvinas (ARVN) Net Cash Flow (2017 - 2026) Analysis & Trends

Arvinas' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$55.6 million for Q1 2026.

  • On a quarterly basis, Net Cash Flow fell 185.13% year-over-year to -$55.6 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 150.4% increase from a year earlier, with the FY2025 full-year figure at $42.4 million, up 119.57% from the prior year.
  • Net Cash Flow slipped to -$55.6 million in Q1 2026 per ARVN's latest filing, from $41.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $198.0 million in Q4 2023 and bottomed at -$223.7 million in Q1 2024.
  • The 5-year median for Net Cash Flow is $15.3 million (2024), against an average of -$1.5 million.
  • Across the five-year window, Net Cash Flow soared 485.96% in 2023 and slumped 557.46% in 2024, its largest moves.
  • Year by year, Net Cash Flow stood at -$51.3 million in 2022, then surged by 485.96% to $198.0 million in 2023, then slumped by 92.27% to $15.3 million in 2024, then soared by 170.59% to $41.4 million in 2025, then tumbled by 234.3% to -$55.6 million in 2026.
  • Per Business Quant, the three latest ARVN Net Cash Flow figures stand at -$55.6 million (Q1 2026), $41.4 million (Q4 2025), and -$13.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 10.56 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 224.46 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.34 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 57.19 Mn
10 Arvinas 519.68 Mn -95.22 Mn - -55.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -55.60 Mn
Mar 31, 2026 -55.60 Mn
Dec 31, 2025 41.40 Mn
Dec 31, 2025 41.40 Mn
Sep 30, 2025 -13.40 Mn
Sep 30, 2025 -13.40 Mn
Jun 30, 2025 33.90 Mn
Jun 30, 2025 33.90 Mn
Mar 31, 2025 -19.50 Mn
Mar 31, 2025 -19.50 Mn
Dec 31, 2024 15.30 Mn
Dec 31, 2024 15.30 Mn
Sep 30, 2024 -75.10 Mn
Sep 30, 2024 -75.10 Mn
Jun 30, 2024 66.80 Mn
Jun 30, 2024 66.80 Mn
Mar 31, 2024 -223.70 Mn
Mar 31, 2024 -223.70 Mn
Dec 31, 2023 198.00 Mn
Dec 31, 2023 198.00 Mn